Calvin Sternick

Stock Analyst at JP Morgan

(2.12)
# 2,886
Out of 4,963 analysts
19
Total ratings
46.15%
Success rate
8.26%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $84.61
Upside: +30.01%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $28.84
Upside: +177.39%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $11.86
Upside: +127.66%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $182.41
Upside: -0.22%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $181.95
Upside: -55.48%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $176.12
Upside: +122.58%